In today's trading, Biosyent Inc opened at $8.53 and closed at $8.50. prices ranged from $8.50 to $8.60.

Share prices gained 0.59% from the previous day's close of $8.45.

During the day across North America, the TSX Composite closed tsx_percentage_change% at 21807.37, the S&P 500 closed sp_500_percentage_change% at 5011.12, the Dow Jones Industrial Average closed dow_jones_percentage_change% at 37775.38 and the Nasdaq Composite closed nasdaq_percentage_change% at 15601.50.

Biosyent Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker RX.

A total of 2,700 shares was traded during the session, with total trades of 8, while having an average volume of 2,880 in the last five days.

The TSX-V market on the whole today saw 2,775 price advancers against 2,424 declines and 120 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have boosted 11.55 percent in the last 12 months, while they have decreased -7.81% since the start of 2024.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $98.10 million on a float of 11,610 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. Currently, there are 1 buy ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..